Suppr超能文献

全植入式 Otologics MET Carina 装置治疗感音神经性听力损失。初步手术和临床结果。

Fully implantable Otologics MET Carina device for the treatment of sensorineural hearing loss. Preliminary surgical and clinical results.

机构信息

Otology and Cochlear Implants Division, University of Pisa, Italy.

出版信息

Acta Otorhinolaryngol Ital. 2009 Apr;29(2):79-85.

Abstract

Middle ear implants overcome some of the common problems of conventional hearing aid technology, such as feedback, signal distortion, ear canal occlusion and associated issues. The Otologics MET Carina, Boulder, CO, USA, is a fully implantable hearing prosthesis designed to address the amplification needs of adults (> 18 years of age), with moderate to severe sensorineural hearing loss and normal middle ears, providing a mechanical direct stimulation of middle ear ossicles. Recently, it has been successfully used also in patients with conductive hearing loss. In the present report, personal surgical and clinical experience with the fully implantable Carina is described in 5 adults with moderate to severe sensorineural hearing loss, operated upon between November 2007 and May 2008 in the ENT Unit, University of Pisa. Mean follow-up was 10.2 months of device use (range 7-13). Surgery was performed under general anaesthesia, in approximately 3 hours, with no surgical complications in any of the patients. In these 5 cases, no significant post-operative variation was observed in hearing thresholds, either for air or bone conduction, indicating absence of surgical damage to the cochlea. All patients showed improvements in hearing thresholds, in free field and in speech perception abilities, with the device functioning, moreover, they reported subjective benefits. With regard to post-operative adverse effects, no cases of extrusion of the device, device failure, loss of external communication or increased charging times were observed. Problems of feedback noise occurred, which were resolved with minor fitting adjustments in 4 cases, while a second operation was required to change the microphone position in the other patient. The present results, in agreement with those reported in the literature, confirm that the Otologics MET Carina is viable treatment for moderate to severe sensorineural hearing loss and, in selected cases, may represent an alternative to conventional hearing aids.

摘要

中耳植入物克服了传统助听器技术的一些常见问题,如反馈、信号失真、耳道堵塞和相关问题。美国科罗拉多州博尔德的 Otologics MET Carina 是一种完全可植入的听力假体,旨在满足成人(> 18 岁)中度至重度感音神经性听力损失和正常中耳的放大需求,提供中耳听小骨的机械直接刺激。最近,它也成功地用于传导性听力损失的患者。在本报告中,描述了 5 例成人中度至重度感音神经性听力损失患者的个人手术和临床经验,这些患者于 2007 年 11 月至 2008 年 5 月在比萨大学耳鼻喉科接受了手术。平均随访时间为设备使用 10.2 个月(范围为 7-13 个月)。手术在全身麻醉下进行,大约 3 小时,所有患者均无手术并发症。在这 5 例患者中,无论是空气传导还是骨传导,听力阈值均无明显的术后变化,表明耳蜗无手术损伤。所有患者的听力阈值在自由场和言语感知能力方面都有所改善,而且设备能够正常工作,他们还报告了主观获益。至于术后不良反应,未观察到设备脱出、设备故障、外部通讯丢失或充电时间增加的情况。发生了反馈噪声问题,在 4 例中通过微小的拟合调整解决,而另一名患者则需要进行第二次手术来改变麦克风位置。目前的结果与文献报道的结果一致,证实 Otologics MET Carina 是治疗中度至重度感音神经性听力损失的可行方法,在某些情况下,它可能是传统助听器的替代方法。

相似文献

2
[Fully implantable middle ear implant--indications, surgical technique and first results].
Otolaryngol Pol. 2011 May-Jun;65(3):236-40. doi: 10.1016/S0030-6657(11)70682-5.
6
Totally Implantable Active Middle Ear Implants.
Otolaryngol Clin North Am. 2019 Apr;52(2):297-309. doi: 10.1016/j.otc.2018.11.011. Epub 2019 Feb 12.
7
Otologics fully implantable hearing system: Phase I trial 1-year results.
Otol Neurotol. 2008 Jun;29(4):534-41. doi: 10.1097/MAO.0b013e3181656969.
9
U.S. Phase I preliminary results of use of the Otologics MET Fully-Implantable Ossicular Stimulator.
Otolaryngol Head Neck Surg. 2007 Aug;137(2):206-12. doi: 10.1016/j.otohns.2007.03.012.

引用本文的文献

2
Optimal Position and Orientation of an Ossicular Accelerometer for Human Auditory Prostheses.
Sensors (Basel). 2024 Dec 18;24(24):8084. doi: 10.3390/s24248084.
3
Sensing Devices for Detecting and Processing Acoustic Signals in Healthcare.
Biosensors (Basel). 2022 Oct 7;12(10):835. doi: 10.3390/bios12100835.
4
Development and Characterization of a Biomimetic Totally Implantable Artificial Basilar Membrane System.
Front Bioeng Biotechnol. 2021 Jul 16;9:693849. doi: 10.3389/fbioe.2021.693849. eCollection 2021.
5
Implantable Hearing Aids: Where are we in 2020?
Laryngoscope Investig Otolaryngol. 2020 Nov 6;5(6):1184-1191. doi: 10.1002/lio2.495. eCollection 2020 Dec.
6
The first results of a totally implanted active middle ear device.
Eur Arch Otorhinolaryngol. 2019 Oct;276(10):2775-2781. doi: 10.1007/s00405-019-05557-8. Epub 2019 Jul 24.
7
Air- and Bone-Conducted Sources of Feedback With an Active Middle Ear Implant.
Ear Hear. 2019 May/Jun;40(3):725-731. doi: 10.1097/AUD.0000000000000655.
8
Implantable hearing devices.
GMS Curr Top Otorhinolaryngol Head Neck Surg. 2017 Dec 18;16:Doc06. doi: 10.3205/cto000145. eCollection 2017.
9
The Carina© middle ear implant: surgical and functional outcomes.
Eur Arch Otorhinolaryngol. 2016 Nov;273(11):3631-3640. doi: 10.1007/s00405-016-3998-1. Epub 2016 Mar 23.
10
A New Trans-Tympanic Microphone Approach for Fully Implantable Hearing Devices.
Sensors (Basel). 2015 Sep 9;15(9):22798-810. doi: 10.3390/s150922798.

本文引用的文献

3
Otologics fully implantable hearing system: Phase I trial 1-year results.
Otol Neurotol. 2008 Jun;29(4):534-41. doi: 10.1097/MAO.0b013e3181656969.
4
Fully implantable hearing device as a new treatment of conductive hearing loss in Franceschetti syndrome.
Int J Pediatr Otorhinolaryngol. 2008 Apr;72(4):513-7. doi: 10.1016/j.ijporl.2007.12.002. Epub 2008 Feb 7.
5
U.S. Phase I preliminary results of use of the Otologics MET Fully-Implantable Ossicular Stimulator.
Otolaryngol Head Neck Surg. 2007 Aug;137(2):206-12. doi: 10.1016/j.otohns.2007.03.012.
6
Intraoperative ossicular loading with the Otologics fully implantable hearing device.
Acta Otolaryngol. 2007 Apr;127(4):360-4. doi: 10.1080/00016480601089424.
7
Fully implantable hearing aids in patients with congenital auricular atresia.
Laryngoscope. 2007 Feb;117(2):336-40. doi: 10.1097/MLG.0b013e31802b6561.
8
Treatment of mixed hearing losses via implantation of a vibratory transducer on the round window.
Int J Audiol. 2006 Oct;45(10):600-8. doi: 10.1080/14992020600840903.
9
Phase 1 clinical trial results of the Envoy System: a totally implantable middle ear device for sensorineural hearing loss.
Otolaryngol Head Neck Surg. 2004 Dec;131(6):904-16. doi: 10.1016/j.otohns.2004.05.027.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验